Greatest fitness of tumor cell subclones in patients undergoing MAPK-targeting therapies requires just-right levels of MAPK pathway signaling. New therapeutic approaches induce tumor cell death by intensifying MAPK signaling induced by inhibitor withdrawal in combination with DNA damage, or prevent selection of resistant clones with a steep fitness barrier imposed by triple combination of BRAF, MEK, and ERK inhibitors. .
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1158/2159-8290.CD-17-1243 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!